Nature Communications (Mar 2020)

Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy

  • Mohamed Mahameed,
  • Shatha Boukeileh,
  • Akram Obiedat,
  • Odai Darawshi,
  • Priya Dipta,
  • Amit Rimon,
  • Gordon McLennan,
  • Rosi Fassler,
  • Dana Reichmann,
  • Rotem Karni,
  • Christian Preisinger,
  • Thomas Wilhelm,
  • Michael Huber,
  • Boaz Tirosh

DOI
https://doi.org/10.1038/s41467-020-15067-5
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 14

Abstract

Read online

Inhibition of PERK, an endoplasmic reticulum (ER) unfolded protein response (UPR) protein, is a potential pharmacological target for cancer treatment. Here, the authors show that inhibition of PERK under ER stress affects trafficking from the ER to the surface of several key receptor tyrosine kinases, suggesting a selective ER retention.